Zanaflex Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Zanaflex General Information
Description
Zanaflex is an essential compound useful in treating serious illnesses. It will be used to produce capsules or tablets for the treatment of spinal cord injuries or multiple sclerosis as well as brain injuries and strokes.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 180 Oyster Point Boulevard
- South San Francisco
- San Francisco, CA
- United States
Zanaflex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|